HoxC8 Inhibitors
The inhibitors listed target various signaling pathways and molecular processes that can indirectly influence the activity or expression of HoxC8. Given HoxC8's role in embryonic development and gene regulation, targeting these pathways may provide indirect means to modulate HoxC8 activity or its downstream effects. Retinoic Acid is crucial in regulating Hox gene expression, and its modulation can significantly impact HoxC8 function during developmental processes. Inhibitors targeting key developmental signaling pathways like Wnt/β-Catenin (XAV-939), Hedgehog (Cyclopamine), TGF-β (SB431542), BMP (LDN-193189), and FGF (PD173074) can indirectly affect the regulatory roles of HoxC8 in these pathways.
Tamoxifen, an estrogen receptor antagonist, can influence gene expression patterns, potentially impacting pathways involving HoxC8. Inhibitors of the JAK/STAT pathway (Tofacitinib) and mTOR (Rapamycin) target key cell signaling mechanisms, which could intersect with HoxC8-related processes. Trichostatin A, an HDAC inhibitor, and 5-Azacytidine, a DNA methyltransferase inhibitor, affect chromatin structure and DNA methylation, respectively, potentially modifying the expression and function of HoxC8. DAPT, a Notch pathway inhibitor, can impact a critical pathway in cell differentiation and development, potentially influencing HoxC8's activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
Targets the Wnt/β-catenin pathway, potentially influencing HoxC8-related developmental processes. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Inhibits the Hedgehog signaling pathway, which could indirectly affect HoxC8 function. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Targets TGF-β receptors, potentially impacting pathways where HoxC8 is involved. | ||||||
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | 1062368-24-4 | sc-476297 | 5 mg | $240.00 | ||
Inhibits BMP type I receptors, potentially affecting HoxC8's modulation of development. | ||||||
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $47.00 $143.00 $680.00 | 16 | |
Targets FGF receptors, which might influence developmental pathways involving HoxC8. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Targets estrogen receptors, potentially influencing gene expression and pathways involving HoxC8. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Affects chromatin structure and gene expression, potentially influencing HoxC8. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
Inhibits the Notch signaling pathway, potentially affecting HoxC8's regulatory network. | ||||||